Literature DB >> 16622139

Neuropsychological and renal effects of dental amalgam in children: a randomized clinical trial.

David C Bellinger1, Felicia Trachtenberg, Lars Barregard, Mary Tavares, Elsa Cernichiari, David Daniel, Sonja McKinlay.   

Abstract

CONTEXT: No randomized trials have been published that address the concern that inhalation of mercury vapor released by amalgam dental restorations causes adverse health effects.
OBJECTIVE: To compare the neuropsychological and renal function of children whose dental caries were restored using amalgam or mercury-free materials. DESIGN AND
SETTING: The New England Children's Amalgam Trial was a 2-group randomized safety trial involving 5 community health dental clinics in Boston, Mass, and 1 in Farmington, Me, between September 1997 and March 2005. PARTICIPANTS AND INTERVENTION: A total of 534 children aged 6 to 10 years at baseline with no prior amalgam restorations and 2 or more posterior teeth with caries were randomly assigned to receive dental restoration of baseline and incident caries during a 5-year follow-up period using either amalgam (n=267) or resin composite (n =267) materials. MAIN OUTCOME MEASURES: The primary neuropsychological outcome was 5-year change in full-scale IQ scores. Secondary outcomes included tests of memory and visuomotor ability. Renal glomerular function was measured by creatinine-adjusted albumin in urine.
RESULTS: Children had a mean of 15 tooth surfaces (median, 14) restored during the 5-year period (range, 0-55). Assignment to the amalgam group was associated with a significantly higher mean urinary mercury level (0.9 vs 0.6 microg/g of creatinine at year 5, P<.001). After adjusting for randomization stratum and other covariates, no statistically significant differences were found between children in the amalgam and composite groups in 5-year change in full-scale IQ score (3.1 vs 2.1, P = .21). The difference in treatment group change scores was 1.0 (95% confidence interval, -0.6 to 2.5) full-scale IQ score point. No statistically significant differences were found for 4-year change in the general memory index (8.1 vs 7.2, P = .34), 4-year change in visuomotor composite (3.8 vs 3.7, P = .93), or year 5 urinary albumin (median, 7.5 vs 7.4 mg/g of creatinine, P = .61).
CONCLUSIONS: In this study, there were no statistically significant differences in adverse neuropsychological or renal effects observed over the 5-year period in children whose caries were restored using dental amalgam or composite materials. Although it is possible that very small IQ effects cannot be ruled out, these findings suggest that the health effects of amalgam restorations in children need not be the basis of treatment decisions when choosing restorative dental materials. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00065988.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16622139     DOI: 10.1001/jama.295.15.1775

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  62 in total

1.  Dental composite materials and renal function in children.

Authors:  F L Trachtenberg; P Shrader; L Barregard; N N Maserejian
Journal:  Br Dent J       Date:  2014-01       Impact factor: 1.626

2.  Colorimetric and fluorogenic recognition of Hg2+ and Cr3+ in acetonitrile and their test paper recognition in aqueous media with the aid of rhodamine based sensors.

Authors:  Rajesh Patidar; Babulal Rebary; Parimal Paul
Journal:  J Fluoresc       Date:  2015-02-10       Impact factor: 2.217

3.  Dental composite restorations and psychosocial function in children.

Authors:  Nancy N Maserejian; Felicia L Trachtenberg; Russ Hauser; Sonja McKinlay; Peter Shrader; Mary Tavares; David C Bellinger
Journal:  Pediatrics       Date:  2012-07-16       Impact factor: 7.124

Review 4.  Environmental exposures and pediatric kidney function and disease: A systematic review.

Authors:  Laura Y Zheng; Alison P Sanders; Jeffrey M Saland; Robert O Wright; Manish Arora
Journal:  Environ Res       Date:  2017-07-17       Impact factor: 6.498

5.  Dental composite restorations and neuropsychological development in children: treatment level analysis from a randomized clinical trial.

Authors:  Nancy N Maserejian; Felicia L Trachtenberg; Russ Hauser; Sonja McKinlay; Peter Shrader; David C Bellinger
Journal:  Neurotoxicology       Date:  2012-08-14       Impact factor: 4.294

6.  Economic impact of regulating the use of amalgam restorations.

Authors:  Tryfon Beazoglou; Stephen Eklund; Dennis Heffley; Jonathan Meiers; L Jackson Brown; Howard Bailit
Journal:  Public Health Rep       Date:  2007 Sep-Oct       Impact factor: 2.792

7.  Nephrotoxicity, neurotoxicity, and mercury exposure among children with and without dental amalgam fillings.

Authors:  Xibiao Ye; Haojun Qian; Peicheng Xu; Lin Zhu; Matthew P Longnecker; Hua Fu
Journal:  Int J Hyg Environ Health       Date:  2008-11-07       Impact factor: 5.840

8.  Prenatal exposure to dental amalgam in the Seychelles Child Development Nutrition Study: associations with neurodevelopmental outcomes at 9 and 30 months.

Authors:  Gene E Watson; Katie Evans; Sally W Thurston; Edwin van Wijngaarden; Julie M W Wallace; Emeir M McSorley; Maxine P Bonham; Maria S Mulhern; Alison J McAfee; Philip W Davidson; Conrad F Shamlaye; J J Strain; Tanzy Love; Grazyna Zareba; Gary J Myers
Journal:  Neurotoxicology       Date:  2012-10-12       Impact factor: 4.294

Review 9.  A review of events that expose children to elemental mercury in the United States.

Authors:  Robin Lee; Dan Middleton; Kathleen Caldwell; Steve Dearwent; Steven Jones; Brian Lewis; Carolyn Monteilh; Mary Ellen Mortensen; Richard Nickle; Kenneth Orloff; Meghan Reger; John Risher; Helen Schurz Rogers; Michelle Watters
Journal:  Environ Health Perspect       Date:  2009-01-12       Impact factor: 9.031

Review 10.  A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials.

Authors:  Ricardo M Fernandes; Johanna H van der Lee; Martin Offringa
Journal:  BMC Pediatr       Date:  2009-12-13       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.